SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-21-000020
Filing Date
2021-06-09
Accepted
2021-06-09 16:06:37
Documents
14
Period of Report
2021-06-08
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ptct-20210608x8k.htm   iXBRL 8-K 56391
2 EX-3.1 ptct-20210608ex31f4f15c6.htm EX-3.1 9753
3 EX-10.1 ptct-20210608ex10141119a.htm EX-10.1 45450
  Complete submission text file 0001070081-21-000020.txt   244301

Data Files

Seq Description Document Type Size
4 EX-101.SCH ptct-20210608.xsd EX-101.SCH 3026
5 EX-101.LAB ptct-20210608_lab.xml EX-101.LAB 15408
6 EX-101.PRE ptct-20210608_pre.xml EX-101.PRE 9800
7 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20210608x8k_htm.xml XML 4636
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 211005206
SIC: 2834 Pharmaceutical Preparations